Soundbites from Hall of Femme: What advice would you give to young women?
We asked Hall of Femme and Women to Watch honorees, along with panelists from the event, to offer advice to young women. Here are some of their responses.
News
The Escalator: BMS names post-deal management team
Plus: BIO names chair for 2019-2020 term.
Five things for pharma marketers to know: Friday, June 7, 2019
U.S. measles cases pass 1,000 mark; Trump administration cuts funding for fetal tissue medical research; Lilly migraine drug approved to treat cluster headaches.
How women executives are preparing tomorrow’s leaders
Top staffers from Havas Health & You, Heartbeat, eHealthcare Solutions and Luminary Labs spoke at MM&M’s Hall of Femme on Thursday.
Vivian Pinn reflects on a career researching women in healthcare
Pinn delivered the keynote at MM&M’s Hall of Femme in New York on Thursday.
Five things for pharma marketers to know: Thursday, June 6, 2019
Ohio doctor faces 25 murder counts for prescribing excess opioid doses; MyCME wins award; Sharpless disputes drug pricing coverage.
How the healthcare industry wants the FDA to regulate cannabis products
The Food and Drug Administration is seeking comments on cannabis-derived products, including CBD.
POC trade group releases draft of revised audit rules
The draft guidelines are designed to instill trust among media buyers that POC vendors are adhering to a unified set of standards.
Chris Palmer promoted to CDM CEO
Kyle Barich, the healthcare advertising network’s former chief executive, stepped down to pursue entrepreneurial opportunities.
Improving outcomes: Applying cognitive science to pharma marketing campaigns
Can applying cognitive science to marketing messaging change medical decision-making? Brian Dunn, Concentric’s Chief Behavioral Officer, explains how the discipline is integrated into campaigns to improve outcomes.
Want to read more?
Please login or register first to view this content.
